ID   DG2 [Mouse hybridoma against human FGF2]
AC   CVCL_E5PP
RX   Patent=WO1991006668A1;
RX   PubMed=2479375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10202.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2 (Note=neutralizing antibody).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   Patent=WO1991006668A1;
RA   Dzubow J.L., Herblin W.F. Jr., Reilly T.M.;
RT   "Monoclonal antibodies to basic fibroblast growth factor that inhibit
RT   its biological activity.";
RL   Patent number WO1991006668A1, 16-May-1991.
//
RX   PubMed=2479375; DOI=10.1016/0006-291x(89)91521-0;
RA   Reilly T.M., Taylor D.S., Herblin W.F. Jr., Thoolen M.J., Chiu A.T.,
RA   Watson D.W., Timmermans P.B.M.W.M.;
RT   "Monoclonal antibodies directed against basic fibroblast growth factor
RT   which inhibit its biological activity in vitro and in vivo.";
RL   Biochem. Biophys. Res. Commun. 164:736-743(1989).
//